During the past decade, CCOP - Atlanta Regional conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 54 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Atlanta Regional" #1 sponsor was "SWOG Cancer Research Network" with 93 trials, followed by "Radiation Therapy Oncology Group" with 41 trials sponsored, "National Cancer Institute (NCI)" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored and "NSABP Foundation Inc" with 18 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Atlanta Regional" #1 collaborator was "National Cancer Institute (NCI)" with 191 trials as a collaborator, "SWOG Cancer Research Network" with 24 trials as a collaborator, "Cancer and Leukemia Group B" with 21 trials as a collaborator, "Eastern Cooperative Oncology Group" with 17 trials as a collaborator and "NCIC Clinical Trials Group" with 16 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Atlanta Regional" are "Breast Cancer" (31 trials), "Lung Cancer" (28 trials), "Lymphoma" (16 trials), "Head and Neck Cancer" (14 trials) and "Leukemia" (13 trials). Many other conditions were trialed in "CCOP - Atlanta Regional" in a lesser frequency.

Most popular intervention types in "CCOP - Atlanta Regional" are "Drug" (183 trials), "Radiation" (64 trials), "Biological" (60 trials), "Other" (49 trials) and "Procedure" (37 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (46 trials), "cisplatin" (26 trials), "Laboratory Biomarker Analysis" (24 trials), "paclitaxel" (24 trials) and "cyclophosphamide" (22 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Atlanta Regional" are 158 trials for "All" genders, 51 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Atlanta Regional". undefined are not yet recruiting, undefined are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 173 completed trials in CCOP - Atlanta Regional, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Atlanta Regional, 12 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".